A novel histone deacetylase 6 inhibitor improves myelination of Schwann cells in a model of Charcot–Marie–Tooth disease type 1A-Reference-Cited by-同舟云学术

A novel histone deacetylase 6 inhibitor improves myelination of Schwann cells in a model of Charcot–Marie–Tooth disease type 1A

Published:2020-09-27 Issue:22 Volume:177 Page:5096-5113
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Ha Nina¹²,Choi Young Il²,Jung Namhee³,Song Ju Young²,Bae Dae Kwon²,Kim Min Cheol²,Lee Yong Jae²,Song Hyeseung²,Kwak Geon¹,Jeong Soyeon³,Park Saeyoung³,Nam Soo Hyun⁴,Jung Sung‐Chul³,Choi Byung‐Ok¹⁴

Affiliation:

1. Department of Health Sciences and Technology, SAIHST Sungkyunkwan University Seoul Republic of Korea

2. CKD Research Institute Yongin Republic of Korea

3. Department of Biochemistry, College of Medicine Ewha Womans University Seoul Republic of Korea

4. Department of Neurology, Samsung Medical Center Sungkyunkwan University School of Medicine Seoul Republic of Korea

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15231

Reference80 articles.

1. Novel HDAC6 Inhibitors Increase Tubulin Acetylation and Rescue Axonal Transport of Mitochondria in a Model of Charcot–Marie–Tooth Type 2F

2. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes

3. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets

4. Inhibition of Histone Deacetylase 6 Acetylates and Disrupts the Chaperone Function of Heat Shock Protein 90

5. The therapeutic hope for HDAC6 inhibitors in malignancy and chronic disease

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small molecules targeting HDAC6 for cancer treatment: Current progress and novel strategies;Biomedicine & Pharmacotherapy;2024-09

2. Targeting histone deacetylases: Emerging applications beyond cancer;Drug Discovery Today;2024-09

3. Will new investigational drugs change the way we treat Charcot-Marie-Tooth disease?;Expert Opinion on Investigational Drugs;2024-05-08

4. Design, synthesis and neuroprotective biological evaluation of novel HDAC6 inhibitors incorporating benzothiadiazinyl systems as cap groups;Chemical Biology & Drug Design;2024-05

5. Molecular mechanisms and therapeutic strategies for neuromuscular diseases;Cellular and Molecular Life Sciences;2024-04-28